Selected eosinophil proteins as markers of inflammation in atopic dermatitis patients

Acta Dermatovenerologica Croatica

Volumn 14, Issue 2, 2006, Pages 73-80

  Jenerowicz, Dorota ^a   Czarnecka Operacz, Magdalena ^a   Silny, Wojciech ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Airborne allergens; Atopic dermatitis; Eosinophil proteins

Indexed keywords

BIOLOGICAL MARKER; EOSINOPHIL PROTEIN X; IMMUNOGLOBULIN E;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EOSINOPHIL; FEMALE; HUMAN; INFLAMMATION; MALE; MEDICAL PARAMETERS; PRICK TEST; PROTEIN ANALYSIS; SCHOOL CHILD; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; DERMATITIS, ATOPIC; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION; MALE; MIDDLE AGED; SKIN TESTS;

EID: 33746155402     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Rasmussen JE, Provost T. Atopic dermatitis. In: Middleton E, Jr, Reed Ce, Ellis EF, eds. Allergy, principles and practice. St. Louis: Mosby Company; 1978. p. 1093.
2. Czarnecka-Operacz M, Silny W. Atopowe zapalenie skóry - aktualny stan wiedzy. Postȩpy Dermatologii i Alergologii 2002; t. XIX,3:152-60.
3. Christophers E. Eosinophilic diseases of the skin. In: Marone G, ed. Human eosinophils. Basel: Karger; 2000. p. 232-42.
4. Czarnecka-Operacz M, Bohdanowicz D, Silny W. Białka pochodzenia eozynofilowego jako wskaźnik stanu zapalnego w badaniach in vitro u chorych na atopowe zapalenie skóry. Postȩpy Dermatologii i Alergologii 2002; t. XIX, 1:38-41.
5. Czech W, Krutmann J, Schopf E, Kapp A. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 1992;126:351-5.
6. Juhlin L, Venge P. Eosinophil cationic protein (ECP) in skin disorders. Acta Derm Venereol (Stockh) 1991;74:495-501.
7. Lacy R, Moqbel R. Eosinophil cytokines. In: Marone G, ed. Human eosinophils. Basel: Karger, 2000;134-48.
8. Thomas LL, Page SM. Inflammatory cell activation by eosinophil granule proteins. In: Marone G, ed. Human eosinophils. Basel: Karger; 2000. p. 99-113.
9. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980;92:44-9.
10. Silny W, Czarnecka-Operacz M, Gołȩbka E et al. Punktowy wskaźnik oceny stanu klinicznego chorych na atopowe zapalenie skóry. Przegl Dermatol 1999;3:215-22.
11. Czarnecka-Operacz M, Bator-Wegner M, Silny W. Atopy patch test reaction to airborne allergens in the diagnosis of atopic dermatitis. Acta Dermatovenerol Croat 2005;13:3-16.
12. Lorette G, Gianetti A, Pereira RS, Leynadier F, Murrieta-Aguttes M. One-year treatment of chronic urticaria with mizolastine: efficacy and safety. J Eur Acad Derm Venereol 2000;14:83-90.
13. Thompson AK, Finn AF, Schoenwetter WF. Effect of 60 mg twice-daily fexofenadine HCI on quality of life, work and classroom productivity and regular activity in patients with chronic idiopathic urticaria. J Am Acad Dermatol 2000;43:24-30.
14. Silny W, Czarnecka-Operacz M. Testy skórne w diagnostyce chorób alergicznych. Postȩpy Dermatologii i Alergologii 2001; t. XVIII, 2:80-4.
15. Slot C. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 1965;17:381-7.
16. Kägi MK, Joller-Jemelka H, Wütrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology 1992;185:88-92.
17. Miyasato M, Tsuda S, Nakama T, Kato K, Kitamura N, Nagaji J, et al. Serum levels of eosinophil cationic protein reflect the state of in vitro degranulation of blood hypodense eosinophils in atopic dermatitis. J Dermatol 1996;23:382-8.
18. Tsuda S, Kato K, Miyasato M, Sasai Y. Eosinophil involvement in atopic dermatitis as reflected by elevated serum levels of eosinophil cationic protein. J Dermatol 1992;19:208-13.
19. Amon U, Memmel U, Stoll R, Amon S. Comparison of severity scoring of atopic dermatitis values and serum levels of eosinophil cationic protein and mast cell tryptase for routine evaluation of atopic dermatitis. Acta Derm Venereol 2000;80:284-6.
20. Toma T, Mizuno K, Okamoto H, Kanegane C, Ohta K, Ikawa Y, et al. Expansion of activated eosinophils in infants with severe atopic dermatitis. Pediatr Int 2005;47:32-8.
21. Ott NL, Gleich GJ, Peterson EA, Fujisawa T, Sur S, Leiferman KM. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction. J Allergy Clin Immunol 1994;94:120-8.
22. Breuer K, Kapp A, Werfel T. Urine eosinophil protein X (EPX) is an in vitro parameter of inflammation in atopic dermatitis of the adult age. Allergy 2001;56:780-4.
23. Oymar K, Bjerknes R. Urinary eosinophil protein X in children with atopic dermatitis: relation to atopy and disease activity. Allergy 2000;55:964-8.
24. Pucci N, Lombardi E, Novembre E. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and children with atopic dermatitis: correlation with disease activity. J Allergy Clin Immunol 2000;105:353-7.
25. Pucci N, Novembre E, Cammarata MG, Bernardini R, Monaco MG, Calogero C, et al. Scoring atopic dermatitis in infants and young children: distinctive features of the SCORAD index. Allergy 2005;60:113-6.
26. Seines A, Dotterud LK. No association between serum eosinophil cationic protein and atopic dermatitis or allergic rhinitis in an unselected population of children. J Eur Acad Derm Venereol 2005;19:61-5.
27. Wolkerstorfer A, Laan MP, Savelkoul HFJ, Neijens HJ, Mulder PG, Oudesluys-Murphy AM, et al. Soluble E-selectin, other markers of inflammation and disease severity in children with atopicdermatitis. BrJ Dermatol 1998;138:431-5.